ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DONALD MILLIGAN

Neurology

4,506

$513K

233
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

JOSHUA GOLDMAN M.D.

Neurology

3,673

$471K

492
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$128
Average prescription price

Avg: $218

PAUL SCHULZ M.D.

Neurology

988

$158K

123
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 28%

$160
Average prescription price

Avg: $218

GRACE MUKAMANA MD

Neurology

1,163

$86.7K

182
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$75
Average prescription price

Avg: $218

ZIMBUL ALBO M.D.

Neurology

574

$174K

111
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 28%

$304
Average prescription price

Avg: $218

HECTOR MALDONADO M.D., PH.D.

Neurology

3,701

$919K

439
300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$248
Average prescription price

Avg: $218

RONALD DEVERE MD

Neurology

1,219

$151K

180
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$124
Average prescription price

Avg: $218

JOSEPH CAMERO MD

Neurology

3,198

$205K

269
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $218

JOHN BERTELSON M.D.

Neurology

1,635

$234K

222
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 28%

$143
Average prescription price

Avg: $218

MARWAN PURGHOL MD

Neurology

2,462

$324K

368
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$132
Average prescription price

Avg: $218

JACK ALPERT MD

Neurology

2,789

$727K

269
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 28%

$261
Average prescription price

Avg: $218

MARY QUICENO M.D.

Neurology

1,220

$266K

184
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 28%

$218
Average prescription price

Avg: $218

MADHUREETA ACHARI MD

Neurology

1,507

$334K

152
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 28%

$222
Average prescription price

Avg: $218

EUGENE LAI M.D., PH.D

Neurology

2,804

$456K

258
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$163
Average prescription price

Avg: $218

RICHARD DEWEY MD

Neurology

1,833

$616K

197
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$336
Average prescription price

Avg: $218

ANN BASS M.D.

Neurology

4,775

$3.3M

396
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 28%

$691
Average prescription price

Avg: $218

DANIEL HYUN MD

Neurology

9,294

$1.42M

1159
786 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $218

LAURA BONDS MD

Neurology

1,539

$193K

230
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$125
Average prescription price

Avg: $218

MOHAMMED ATHARI M.D.

Neurology

5,483

$490K

399
223 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

MIGUEL GUTIERREZ M.D.

Neurology

22,365

$2.87M

1861
1343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$129
Average prescription price

Avg: $218

MARCO BENITEZ M.D

Neurology

4,726

$1.62M

479
338 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$343
Average prescription price

Avg: $218

JOOHI JIMENEZ-SHAHED M.D.

Neurology

3,159

$2.61M

324
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$828
Average prescription price

Avg: $218

CHERRY MATHEW MD

Neurology

3,201

$364K

334
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

GEORGE PLOTKIN MD

Neurology

6,232

$1.3M

534
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 28%

$209
Average prescription price

Avg: $218

ROGER BLAIR M.D.

Neurology

2,565

$662K

319
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 28%

$258
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank